https://markets.financialcontent.com/fatpitch.financials/quote/news?CurrentPage=3&Symbol=NY%3ANNVC&ChannelType=PRESSRELEASES
Fat Pitch Financials - Latest News about NanoViricides, Inc. Common Stock (NYSE:NNVC) |...
latest newscommon stockfatpitchfinancials
https://www.siliconinvestor.com/subject.aspx?subjectid=55797
NNVC - NanoViricides, Inc. | Stock Discussion Forums
NanoViricides Has Filed Annual Report, Says Company Has Sufficient Cash To Advance Into Clinical Trials SHELTON, CONNECTICUT -- Friday, September, 29, 2017 --...
discussion forumsnnvcincstock
https://www.smallcaprelations.com/clients/nanoviricides-inc/?symbol=nnvc
NanoViricides Inc. (NYSE American: NNVC) - SmallCapRelations
Investment Considerations NanoViricides is pioneering a novel class of nanomedicine-based antiviral therapies, offering a unique and potentially disruptive...
nyse americanincnnvc
https://www.finanzwire.com/press-release/nanoviricides-inc-nasdaq-nnvc-nv-387-for-the-treatment-of-measles-is-granted-orphan-drug-designation-by-the-us-fda-1iGue0xAWGt
NanoViricides, Inc. (NASDAQ:NNVC) | NV-387 for The Treatment of Measles is Granted Orphan Drug...
May 4, 2026 - NanoViricides, Inc. receives US FDA Orphan Drug Designation for antiviral drug NV-387, targeting Measles treatment. The drug shows strong efficacy in in vivo...
for theincnasdaqnnvctreatment